Skip to content
2000
Volume 3, Issue 7
  • ISSN: 1568-0266
  • E-ISSN: 1873-4294

Abstract

Recent studies have demonstrated that protein tyrosine phosphatase 1B (PTP1B) is involved in the down regulation of insulin signaling. Selective inhibitors of PTP1B hold much promise for the treatment of type 2 diabetes mellitus and obesity. Consequently much effort, by both industry and academia, has been devoted towards the development of PTP1B specific inhibitors. This article gives an overview of reports that have appeared in the primary scientific literature on the development of PTP1B inhibitors, starting from the days of early development up to September of 2002.

Loading

Article metrics loading...

/content/journals/ctmc/10.2174/1568026033452311
2003-03-01
2025-05-07
Loading full text...

Full text loading...

/content/journals/ctmc/10.2174/1568026033452311
Loading

  • Article Type:
    Review Article
Keyword(s): Protein Tyrosine Phosphatase
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test